hFcRn(SD)
Nomenclature
SD-Fcgrtem1(hFCGRT)Smoc
Cat. NO.
NR-HU-200002
Strain State
Repository Live
Gene Summary
Gene Symbol
Fcgrt
Model Description
Validation Data
Fig1. Expression characterization of hFCRN in hFCRN knockin rat by Western blot.
Abbr. HO, homozygous; WT, wild type.
Fig.2 Blood concentration curve of test articles in hFcRn/hALB dKI rats (NR-HU-233317), which were generated by crossing hFCRN(SD)(NR-HU-200002) with hALB(SD)(NR-HU-200001).
In hFcRn/hALB dKI rats, the half-life time: TA-N434A > TA-YTE > TA. (In cooperation with the third party)
Fig.3 PK study of Keytruda (A) and Cyramza(B) in hALB/hFCRN dKl rat (NR-HU-233317), which were generated by crossing hFCRN(SD)(NR-HU-200002) with hALB(SD)(NR-HU-200001). (n=3/time point/group)
Fig.4 Pharmacokinetic analysis of IBI112 in hFCRN(SD) rat. (A) Body weight. (B) Pharmacokinetic analysis parameters. On Day 0, Sprague-Dawley (SD) rats and hFcRn(SD) transgenic rats were intravenously injected via the tail vein with IBI112 (hIgG1 Fc) and the YTE-modified IBI112 antibody (5 mg/kg), respectively. Blood was drawn at the indicated times, and serum was obtained for pharmacokinetic analysis (n=3 females, 6-8 weeks old). The results revealed a significantly prolonged half-life of the YTE-modified IBI112 antibody in hFcRn(SD) rats compared to wild-type (WT) SD rats.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
